Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Home
About
Overview
Open Source Software
Help
History (1)
Predictors of resistance to preoperative trastuzumab and vinorelbine for HER2-positive early breast cancer.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Predictors of resistance to preoperative trastuzumab and vinorelbine for HER2-positive early breast cancer.
Predictors of resistance to preoperative trastuzumab and vinorelbine for HER2-positive early breast cancer. Clin Cancer Res. 2007 Feb 15; 13(4):1198-207.
View in:
PubMed
subject areas
Antibodies, Monoclonal
Antineoplastic Combined Chemotherapy Protocols
Breast Neoplasms
Chemotherapy, Adjuvant
Cyclophosphamide
Doxorubicin
Drug Resistance, Neoplasm
Female
Genes, erbB-2
Humans
Male
Predictive Value of Tests
Preoperative Care
Receptor, erbB-2
Vinblastine
authors with profiles
James Dirk Iglehart, M.D.
Steven Eliot Come, M.D.
Harold John Burstein, Ph.D., M.D.
Stuart Jay Schnitt, M.D.
Eric Paul Winer, M.D.
Dennis Charles Sgroi, M.D.
Rebecca Sue Gelman, Ph.D.